Can the Efficacy of [<sup>18</sup>F]FDG-PET/CT in Clinical Oncology Be Enhanced by Screening Biomolecular Profiles?

Can the Efficacy of [<sup>18</sup>F]FDG-PET/CT in Clinical Oncology Be Enhanced by Screening Biomolecular Profiles?

Positron Emission Tomography (PET) is a functional imaging modality widely used in clinical oncology. Over the years the sensitivity and specificity of PET has improved with the advent of specific radiotracers, increased technical accuracy of PET scanners and incremental experience of Radiologists....

Full description

Bibliographic Details
Main Authors: Hazel O’Neill, Vinod Malik, Ciaran Johnston, John V Reynolds, Jacintha O’Sullivan
Format: Article
Language:English
Published: MDPI AG 2019-01-01
Series:Pharmaceuticals
Subjects:
[<sup>18</sup>F]FDG PET/CT
biomarker profiling
cancer
Online Access:https://www.mdpi.com/1424-8247/12/1/16

Similar Items

Similar Items